Shkreli, Sporting Prison Fatigues and a Beard, Returns to Court
(Bloomberg) -- Martin Shkreli, clad in prison fatigues and sporting a scruffy beard, returned to court for the first time since his jailing in September, hoping to convince a judge that he shouldn't have to forfeit money to the U.S. government.
For 90 minutes in federal court in Brooklyn, New York, on Friday, Shkreli fidgeted and smirked only occasionally as his legal team assailed the prosecutor's request that he surrender $7.4 million he allegedly reaped from his frauds. His mother, Katrina, was also in court for the first time since her son's December 2015 arrest.
Now with prison-issued glasses instead of the wireless spectacles or contacts he wore at the trial, Shkreli listened closely as his lawyer argued that he generated "robust returns" for his hedge fund investors, didn't steal their money, and shouldn't have to pay a cent.
"At the end of the day, investors made substantial amounts of money," defense lawyer Benjamin Brafman told the judge.
It was a far cry from Shkreli's behavior at his trial last summer, when he frequently rolled his eyes during testimony from government witnesses, hurled angry outbursts at reporters and mocked prosecutors. He appeared to realize that U.S. District Judge Kiyo Matsumoto's ruling would not only determine what he owes but will influence how much time he spends behind bars. Shkreli's sentencing, scheduled for March 9, will be based in part on the amount of investor losses.
Shkreli, a 34-year-old hedge-fund-manager-turned-biotech-founder, was accused of defrauding investors in his funds, losing their money in bad trades, and paying them back with assets from the drug firm he launched, Retrophin Inc. He was convicted in August of lying to the investors and scheming to manipulate the drug firm's shares, but acquitted of stealing from the company.
Martin Shkreli's Fall: Why ‘Most-Hated' CEO Is Strutting to Jail
The judge didn't rule on the forfeiture amount, but she did reject Shkreli's request to toss out his conviction. Despite his argument that prosecutors misled jurors about the law, the evidence presented at the trial was "was more than sufficient" to warrant a conviction, Matsumoto told lawyers.
Matsumoto ordered Shkreli jailed in September for issuing a bounty on social media for a sample of former Secretary of State Hillary Clinton's hair.
Shkreli's assets include a Picasso, $5 million in his personal trading account, a one-of-a-kind special edition album by the Wu-Tang Clan and his shares in Vyera Pharmaceuticals -- formerly called Turing Pharmaceuticals, according to prosecutors.
Prosecutors on Friday argued that Shkreli cost his investors more than $20 million by inducing them to put millions of dollars into his two hedge funds which operated essentially like Ponzi schemes. Assistant U.S. Attorney Alix Smith said he spent investor funds on personal expenses "to maintain the image of a successful hedge fund manager."
"The monies Shkreli got from his investors were the lifeblood of his fraud schemes," Assistant U.S. Attorney Claire Kedeshian said. "Like a bandit or a thief, he took money from one to pay off another and used it for his own benefit."
Matsumoto skeptically questioned Brafman's argument that Shkreli should get credit for repaying investors in his failed hedge funds with Retrophin shares -- which the defense says eventually paid out substantial profits.
"What you're saying is any convicted fraudster could never face forfeiture as long as they used the money in something that went completely bust," said the judge, who didn't immediately rule.
--With assistance from Christie Smythe
To contact the reporter on this story: Patricia Hurtado in Federal Court in Manhattan at pathurtado@bloomberg.net.
To contact the editors responsible for this story: David Glovin at dglovin@bloomberg.net, Peter Blumberg
©2018 Bloomberg L.P.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets